Logo | Name | Σ | Employees | ||
---|---|---|---|---|---|
LoQus23 Therapeutics Ltd Stopping DNA instability; Slowing neurodegenerative disease LoQus23 are discovering oral small molecule therapies targeting aberrant DNA mismatch repair to effectively treat Huntington’s and other triplet repeat diseases. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 0 | 1 | 10 | |
MONCYTE Health Unique technology and novel data for personalized and optimal treatment of high cholesterol MONCYTE Health has a unique proprietary technology to quantify individual differences in cellular lipid uptake and storage which contribute to high blood cholesterol and the effectiveness of common lipid-lowering drugs. The readouts are derived from white blood cells, including monocytes, which play key roles in atherosclerotic plaque formation and inflammation, linking directly to cardiovascular risk. Precisely quantifying these individual differences enables personalized treatment strategies in combination with risk assessment which can help patients more effectively achieve optimal blood cholesterol levels faster, and thereby reduce the risk for … Type: Startup Activities: deeptech biotech Technologies: Data Analytics Synthetic Biology | 0 | 0 | 0 | 3 | |
Lexicon Pharmaceuticals, Inc. At Lexicon, We Pioneer Medicines that Transform Patients' Lives Corporate Overview Lexicon Pharmaceuticals is a biopharmaceutical company that has harnessed the power of genetics for drug discovery. Our research team has generated a pipeline of novel drug candidates in clinical development across a broad range of indications. The Genome: Our Source of Discovery We have applied gene knockout technology to thousands of potential drug targets encoded in the human genome. Our scientists have gained a thorough understanding of target biology and identified new points of intervention for future therapies. We have integrated a series of recombinant DNA and chemistry technologies … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 420 | |
U.S. Military HIV Research Program At the Forefront of the Battle Against HIV MHRP is at the forefront of the battle against HIV. Our mission is to protect U.S. Service Members from HIV and improve global health by conducting research to develop an HIV vaccine, reduce new infections and advance strategies to induce long-term HIV remission. With an international network of research sites throughout Africa and Asia, the program’s growth and success has been achieved through a combination of strong science, careful development of research sites and partnerships with key research institutions in the U.S. and host countries. Since its inception in 1986, MHRP has … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 2 | 1 | 1 | 39 | |
Vivani Vivani Medical is a pre-clinical-stage developer of long-term pharmaceutical implants aimed at revolutionizing the treatment of patients with chronic diseases. Leveraging its proprietary NanoPortalTM platform, Vivani’s portfolio of tiny, sub-dermal drug implants address medication non-adherence by providing steady levels of medication over a target duration of six months or longer. Vivani is developing two miniature, long-term GLP-1 implants for the treatment of obesity and chronic weight management: NPM-115 (exenatide) and NPM-139 (semaglutide). In addition, the company is developing NPM-119, a lower dose exenatide implant for the treatment of type 2 diabetes. Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 4 | 1 | 3 | 31 | |
Eurofins BioPharma Product Testing Italy Laboratory Testing Excellence Eurofins Biolab S.r.l. is a GMP & GLP Laboratory part of the BioPharma Product Testing Division of Eurofins Scientific. Pharmaceuticals, Medical Devices, Biocides and Cosmetics are our main areas of interest GMP, GLP, ISO 17025, ISO 9001, ISO 13485, ISO 22716, FDA INSPECTED, BioPharmaceutical Testing, Medical Device Testing, Biocide Testing, Cosmetic Testing, Professional Scientific Services, Regulatory and Consultancy, Microbiological and Chemical Testing, Training, and Laboratory Testing Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 1 | 0 | 428 | |
Centennial Optical Limited Centennial Optical is an independent, Canadian-owned company since 1967. Keeping You in Sight Centennial Optical is an independent, Canadian-owned company distributing ophthalmic frames and lenses, sunglasses, lab supplies, cases and accessories, nationally and internationally. Founded in 1967, Centennial sells optical goods and services to Eye Care Professionals (Optometrists, Opticians and Ophthalmologists), optical laboratories and optical retailers. Centennial is fully licensed by Health Canada to sell Class I and Class II medical devices. With corporate headquarters and central distribution located in Toronto, Centennial also has local distribution centers and customer service in Montreal and Vancouver. Toujours en vue Optique Centennial est … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 2 | 0 | 0 | 95 | |
Keeler Focused on helping our global community bring an end to preventable vision loss. #ThriveWithKeeler Elevate your eyecare with Keeler – your global partner for reliable screening, diagnosis, and treatment outcomes. With over 100years of expertise, we are focused on supporting your in-practice and on-the-go needs. Designed in collaboration with clinicians, equipped with exceptional optics and featuring ergonomic shapes and controls, Keeler products are robust, intuitive and comfortable. Beyond being a manufacturer, we are your collaborator within the eyecare industry. We are committed to knowledge sharing, innovation and unwavering quality to help enhance your patient care and streamline operations. Our US … Type: SMB Activities: healthtech manufacturing Technologies: Synthetic Biology | 1 | 1 | 1 | 213 | |
Karten Design We Create Extraordinary Experiences In Healthcare Karten Design is an award-winning product design and innovation consultancy passionate about creating extraordinary experiences between people and products. For 40 years, we have helped leading consumer product and medical device companies seize new opportunities, build their brands, and generate revenue by designing and developing beautiful, easy-to-use products that resonate with end users. EXPERTISE Medical Product Innovation Inspired by deep empathy for the needs of patients, caregivers, and clinical professionals, we create health solutions that people love, increasing adoption and adherence. Digital Health Product Innovation Leveraging our 30 years of experience translating people’s complex … Type: SMB Activities: uxtech Technologies: Synthetic Biology | 0 | 0 | 0 | 15 | |
Sahajanand Medical Technologies Pledge to save millions We are a leading developer and manufacturer of minimally invasive coronary stent systems, with one of the broadest product portfolios in the industry. We have a strong international presence with footprints in more than75 countries. We at SMT believe in continuous innovation and up-gradation of our portfolio in order to cater your healthcare needs. Our commitment is to advance the patient care by introducing state of the art medical devices which will enable us to save precious lives. We are committed to the welfare of all the patients around the world. We are proud to be … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 855 | |
Elektronik [Automatic translation follows] Electronics - The platform for expert knowledge. News and specialist articles for engineers, technical developers and researchers. Print & Digital - hand-picked by our editorial team. The specialist medium 'Electronics' provides cross-medial information about solutions and components of professional electronics. We cover the "hot" topics along the value chain and offer a comprehensive overview of manufacturers and distributors. This makes our brand 'Elektronik' unique in B2B communication. From research to technology implementation and rounded off by the relevant economic and trend topics, 'Elektronik' is the perfect source of information for electronics developers, technical purchasing/sales/business development and support … Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology | 16 | 0 | 16 | 7 | |
Pietro Turilli Senior Vice President, External Affairs at the TB Alliance. Helping to build the political will and mobilize resources necessary to end TB. Views are my own. Type: SMB Activities: deeptech Technologies: Synthetic Biology | 1 | 0 | 0 | N/A | |
Blythedale Children's Hospital We are a specialty children's hospital dedicated to improving the health of all kids with complex medical conditions. Blythedale Children's Hospital in Westchester County, New York is dedicated exclusively to the diagnosis, care and treatment of children with complex medical and rehabilitative needs. Blythedale is a national leader in developing innovative, multi-disciplinary inpatient and ambulatory programs, as well as a community resource for children with a variety of medical concerns. Acquired Brain Injury, Assistive Technology, Cancer Rehabilitation, Cardiac Rehabilitation, Complex Chronic Conditions, Complex Post-Surgical Rehabilitation, Complex Wound and Burn Management, Neuromuscular Disorders, Post Acute Neonatal Care, Pre/Post Organ & Stem … Type: SMB Activities: healthtech kidtech Technologies: Synthetic Biology | 2 | 0 | 2 | 438 | |
Hospital Universitario Nuestra Señora del Rosario [Automatic translation follows] Open hospital where we combine humanization and technique, hospitality and professionalism, demand and affection. The Hospital Nuestra Señora del Rosario is a reference medical-surgical center, managed by the Congregation of the Sisters of Charity of Santa Ana, located in the heart of Madrid. With a wide range of specialties and a neonatal and adult emergency service that operates 24 hours a day, it stands out in the fields of Neurosciences (Neurology, Neurosurgery, Endovascular Therapy and Neurodiagnosis by Imaging), Cardiology, Obstetrics and Gynecology, Orthopedic Surgery and Traumatology, Plastic, Aesthetic and Reconstructive Surgery and Urology. It has cutting-edge technological … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 370 | |
Global D [Automatic translation follows] Partner of your Surgeries Global D is a French company, specialized in the design, manufacture and provision of quality medical devices intended for maxillofacial, pre-implant, orthodontic surgeries and dental implantology. Global D, partner of your surgeries. a company of the Menix group medical devices, dental implants, and max-fac implants Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 7 | 1 | 6 | 168 | |
INSTITUT FRANCAIS D'HYPNOSE - IFH [Automatic translation follows] Professional training and research center since 1990 The French Institute of Hypnosis (IFH) is a training and research center founded in 1990 to study and train in the use of hypnosis in a therapeutic context. 🧑⚕️ For more than 30 years, we have been designing, delivering and developing hypnosis training for medical and psychotherapeutic purposes, based on the most recent scientific research and field practices, in order to contribute to improving the professional skills of practitioners. 🏥 Our training courses are available in Inter and Intra hospital. 🫶 Our values: - Humanity and ethics, at the heart … Type: SMB Activities: edtech Technologies: Synthetic Biology | 0 | 0 | 0 | 27 | |
IntegraGen IntegraGen is an OncoDNA group company specializing in the genomics of cancer and rare genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in DNA sequencing services and genomic data interpretation software. The company runs one of the largest NGS labs in France and operates for research institutes of excellence. As part of OncoDNA group, IntegraGen leverages the power of next generation sequencing with the mission of delivering the promise of precision medicine to patients. IntegraGen has about 50 employees and generated €9 million of revenue in 2020. Based in France, IntegraGen is also present … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 6 | 4 | 2 | 55 | |
Protilab [Automatic translation follows] Smile creator for all Created in 2006, Protilab is the only ISO certified dental prosthesis laboratory in its sector. The work is carried out in its ultra-modern dental prosthesis laboratory certified ISO 9001:2008 and ISO 13485:2003. Protilab has, in its Parisian premises, a fully equipped laboratory allowing the realization and repair of all work in express. Protilab offers 5 quality commitments: • Certification • Materials • Traceability • Monitoring • Guarantee dental prosthesis laboratory, joint prostheses, removable prostheses, CAD/CAM, Digital impression management, and prostheses on implants Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 38 | |
Pherecydes Pharma At the forefront of the fight against antibioresistant bacteria Pherecydes Pharma develops antibacterial treatments based on the use of bacteriophage viruses, or phages, to fight bacterial infections in humans, particularly those resistant to antibiotics. Phages are natural predators of bacteria and have no demonstrated effect on eukaryotic cells, including human cells. Antimicrobial resistant bacteria or AMR are responsible for over 700,000 death a year in 2014 according to the WHO. This number might reach over 10,000,000 by 2050 if nothing is done, and no new class of antibiotics has been discovered in the last 30 years. Phages represent one of … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 10 | 4 | 8 | |
Evamed [Automatic translation follows] Experts in the clinical evaluation of medical devices Evamed is a C.R.O expert in the clinical evaluation of medical devices. We support manufacturers, learned societies and public bodies on their interventional studies, registries and observational studies. Our experience and Evamed's strong medical device culture make it a trusted player and a privileged partner for your clinical study projects. We can support you throughout your project (Protocol, eCRF, Steering, Monitoring, Data-management, Statistics, Reports) or collaborate on specific stages. Do you want to carry out a post-marketing surveillance study, obtain your CE marking or your reimbursement? Evamed ensures the … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 8 | 3 | 7 | 38 | |
Euro-Pharmat [Automatic translation follows] Expertise, skills, training, objective information for the proper use of medical devices. Objective, validated information on Sterile Medical Devices. For nearly 40 years, the experience of real-time information. A training activity through annual National Days and a training catalog. French pharmaceutical learned society of medical devices defined by its new statutes in 2021. Information Database and Training Organization Type: SMB Activities: deeptech healthtech it services Technologies: Synthetic Biology | 14 | 2 | 11 | 8 | |
Dynamic42 GmbH Develop human organ models with true physiological complexity We are specialized in the production and development of human, immunocompetent Organ-on-Chip technology for in vitro disease and infection modelling. Organ-on-Chip, Human Cell Biology, Infection, Infectious disease, Toxicity profiling, Immune Cell Interactions, Inflammatory Diseases, Antibody recycling, and Uptake / Transport studies Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 23 | |
Cytochroma Accelerating global drug development Cytochroma predict how drugs will react in a global population in health or disease. Our unique, ethnically diverse library of iPSC and automated cell culture generates robust, reliable, mature hepatocytes for toxicity testing. We are supporting life science companies, de-risking safe compounds prior to clinical testing, making new drug development faster, safer and more efficient. toxicity testing, liver specialists, hepatocyte testing, disease models, high throughput, high content screening, iPSC, automated manufacture, machine learning, artificial intelligence, predictive testing, and pre clinical testing Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology | 2 | 0 | 3 | 2 | |
Eat Just, Inc. Our mission is to build a food system where everyone eats well. Eat Just is a food technology company with a mission to build a healthier, safer and more sustainable food system in our lifetimes. The company’s expertise, from functionalizing plant proteins to culturing animal cells, is powered by a world-class team of scientists and chefs spanning more than a dozen research disciplines. Eat Just created America’s fastest-growing egg brand, which is made entirely of plants, and the world’s first-to-market meat made from animal cells instead of slaughtered livestock. food science, food, science, culinary, food production, vegan, vegetarian, cultured meat, … Type: Startup Activities: foodtech healthtech Technologies: Synthetic Biology | 12 | 3 | 6 | 263 | |
Dosepharma [Automatic translation follows] Dosepharma, the blistering service provider for pharmacists. Founded in 2013, Dosepharma specializes in the packaging of medicines (Blistering). Certified by Swissmedic, our company stands out for its personalized and high-quality Blistering services. In our laboratory, doses of personalized medicines are blistered in a robotized, highly controlled manner and in compliance with the highest safety standards. We work every day to relieve patients in their medication intake and allow pharmacists to benefit from a tailor-made service for their patients. Technology, Automation, Medicine, Digital, Pharmacy, IT, challenger mindset, and unit sales Type: Startup Activities: it services Technologies: Synthetic Biology | 0 | 0 | 0 | 11 | |
CRISPR Therapeutics CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 12 | 5 | 5 | 442 | |
COAT-X We are world leader for the ultra-hermetic thin film packaging of electronics, sensors and sensitive components. We are an independant Swiss SME created in 2016 by a few experts in thin film technology and medical devices. Our unique Parylene multilayer technology protects sensitive industrial and implantable electronics for the very long-term. Under ISO 13485 certification, in clean room and with our proprietary chemical vapor deposition machines, we offer premium coating service to legal and contract medical device manufacturers. Microtechnology, Multilayer, Parylene, Thin-film, Coating, PCB, Medical device, Parylene+, Implants, Encapsulation, Barrier film, Advanced electronics packaging, Protection of PCB, Long term encapsulation, … Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 6 | 1 | 2 | 12 | |
CleanSlate UV CleanSlate UV is a biosafety company creating the next generation of intelligent sanitization solutions. CleanSlate UV is a biosafety company creating the next generation of intelligent sanitization solutions. We leverage the power of UV-C light to kill the most dangerous bacteria and viruses without damaging devices. With a focus on rigorously tested and intuitive products, CleanSlate UV is trusted by world-class facilities, from hospitals to five-star hotels. Ultra-violet light, Healthcare, Mobile device disinfection, Smartphone sanitizer, Food processing, Food safety and quality control, Medical Devices, uv light, and infection control Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 2 | 0 | 1 | 1 | |
Civilization Ventures Early-stage life sciences investment firm supporting category-defining technologies in healthcare At CV, we champion visionary founders tackling the most critical challenges in biology and healthcare. With a portfolio worth $9.7B, encompassing 64 companies and 9 successful exits, we provide the capital and resources necessary for innovators to thrive. Type: Startup Activities: deeptech healthtech Technologies: A.I. Synthetic Biology | 25 | 0 | 25 | 11 | |
Brave Health Taking control of your mental health? Now that's Brave. Brave Health provides telehealth-enabled mental health care solutions for health plans including individual therapy, psychiatry and medication management, marriage and family counseling, clinician-led group therapy and specialized therapeutic programs. We are in-network with more than 200 insurance plans, including commercial, Medicaid and Medicare. mental health, behavioral health, community health, telehealth, addiction, psychiatry, community mental health, telemedicine, Socialwork, casemanagement, healthandwellness, medicationmanagement, digitalage, techsavvy, technologybased, and healthcare Type: Startup Activities: healthtech Technologies: Synthetic Biology | 10 | 5 | 3 | 197 | |
AYOXXA Biosystems GmbH AYOXXA – the Translational Proteomics Company. Understanding complex biology from bench to bedside. AYOXXA - The translational proteomics company AYOXXA Biosystems GmbH, based in Cologne (Germany), is an international biotech company focused on the development of its proprietary beads-on-a-chip technology for advanced protein analysis. LUNARISTM. AYOXXA’s innovative multiplex protein analysis platform is a fully integrated system designed for the parallel analysis of multiple biomarkers in picogram amounts of biological samples, allowing scientists to gain a maximum of high quality and reproducible insights. LUNARISTM is fully scalable, with integrated, image-based quality control and transparent data processing and management, enabling translational proteomics … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 2 | 1 | 23 | |
Uluu From the ocean, for the planet Uluu is an exciting new biomaterial that's incredible for our oceans and climate. It fights global warming by sequestering carbon in anything, and everything, that's built with it. It's biodegradable - so it won't harm our environment or the creatures living in it. And, it's made from seaweed - an amazing, renewable resource, which cleans up our oceans, promotes marine biodiversity, yet doesn’t displace precious farmland. Uluu - reviving the world. Type: Startup Activities: cleantech greentech Technologies: Decarbonization New Materials Synthetic Biology | 7 | 1 | 4 | 15 | |
Amino Labs Make with Biology Amino Labs' mission is to make biotechnology learning and innovation accessible to teenagers, educators, and adults. Youtube: https://www.youtube.com/c/AminoLabs Education, Genetic Engineering, STEM, Hands-on Experiments, Zero to Genetic Engineering Hero, biology kits, STEAM, and science education Type: Startup Activities: deeptech industry 4.0 Technologies: Synthetic Biology | 3 | 0 | 2 | 3 | |
Ripple Foods Plant-based dairy alternatives that are good for you and good for the planet. We are dedicated to changing the standard of what plant-based foods can be. 🌱 Plant-Based Milks and Protein Shakes 🌱 Created by the genius of plants 🌱 Certified B-Corp 🌱 Top 8 Allergen-Free 🌱 Vegan and Certified Non-GMO Food, Alternative Dairy, Technology, and Sustainability Type: Startup Activities: foodtech Technologies: Synthetic Biology | 9 | 3 | 3 | 80 | |
ZeaKal, Inc Carbon to Nutrition | Helping crops capture more carbon and sunlight, leading to healthier, nutrient-rich food and feed. ZeaKal is a plant traits innovator that helps crops capture more carbon and sunlight, leading to healthier, nutrient-rich food and feed. We are committed to building a more equitable and resilient agricultural system on a smaller environmental footprint. Discover how we are building a “NewType” Tomorrow at zeakal.com Our plant traits dramatically improve the yield and composition of staple crops, resulting in carbon capture for better nutrition, as well as higher incomes, lower costs, and efficiencies along the ag supply chain. Agbiotech, … Type: Startup Activities: cleantech greentech Technologies: Decarbonization Synthetic Biology | 0 | 0 | 0 | 10 | |
Axithra Rapid Therapeutic Drug Monitoring Axithra is a spin-off from Ghent University and imec, developing a platform to quickly and accurately measure and monitor drug concentrations in blood, paving the way for treatments tailored to the specific needs of each individual, at any given time. The first application is focusing on personalizing beta-lactam antibiotics treatments in the intensive care unit. The company’s platform is based on proprietary optical and photonics technology and will allow physicians to optimize patient care by enabling personalized treatments. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 11 | |
Odyssey SpaceWorks R&D labs in space enabling observation and engineering of biological systems from earth. Odyssey SpaceWorks builds science labs in space enabling researchers to make discoveries that are impossible on earth. Our R&D labs which offer direct control from earth, allow for observation, construction, and engineering of biological systems in a reliable, predictable fashion. Applications include Tissue Engineering, Therapeutics, Cancer Biology, Agriculture, Drug Safety, and more. Type: Startup Activities: spacetech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 6 | |
ImmuneBridge Amplifying nature’s innate intelligence to fight cancer ImmuneBridge is developing allogeneic immunotherapies for cancer. Our core technology drives the expansion of cord blood derived immune stem cells and establishes a novel, flexible, consistent and abundant cellular source for immunotherapies. We are currently pursuing natural killer cell products for hematological malignancies. Next we will use the unique advantages of our cellular source to tackle solid tumors. Platform ImmuneBridge is creating a platform of scalable allogeneic immune cell therapies from cord blood. Our proprietary technology, including a novel small molecule, expands cord blood HSPCs over 100,000-fold while maintaining full immune multipotency, with … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 26 | |
genedrive Advancing Diagnostics to the Point Of Care genedrive plc is a molecular diagnostics company developing and commercialising a low-cost, rapid, versatile, simple to use and robust point of need molecular platform for use in patient stratification (genotyping). We are passionate about the opportunity to build a sustainable business around molecular diagnostics and to play an important role in the diagnostic and treatment challenges presented by global health issues. The company launched the Genedrive MT-RNR1 ID Kit, a pharmacogenetic test to prevent antibiotic induced deafness in infants, which was co-developed with the partners in the UK's National Health Service and is … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 1 | 48 | |
DTF medical NOUS AGISSONS POUR ACCOMPAGNER LA VIE Based in Saint Etienne (France) since 1951, DTF medical specializes in the design, manufacture and sale of top-quality, innovative medical devices. This family owned company, which have been managed by two founding families members for three generations, is recognized via the brands Kitett, Atomisor and Matelas DTF in France and abroad. Backed by powerful research capabilities, an enthusiastic and committed personnel, DTF medical serves the needs of patients and care professional alike. Its mission is to serve and assist them at every life stage. Breast feeding, Aerosothearpy & Nebulizing, Pressure Ulcer Prevention & Treatment, … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 2 | 2 | 1 | 64 | |
STRATEGIQUAL SAS Strategiqual is a consulting company located in the center of Paris and operating in Europe, with extensive experience in Europe and the US. Its area of expertise covers pharmaceutical products, medical devices and biotechnology. Strategiqual has in-house expertise in the areas of regulatory affairs, strategic plans, gap analysis, risk analysis, audits, product compliance, quality management systems implementation. Specialties : - Systems approach for designing Quality Management Systems (pharmaceutical products, medical devices, biotechnology) - Drug device combinations (the so called "rule 13" of directive 93/42/CEE) - Innovative medical devices: quality and regulatory approaches Strategiqual is part of ProductLife Group (PLG) since … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 6 | 6 | 1 | 61 | |
AXEME Récoltez le talent, cultivez l'innovation ! Founded in 2004, Axeme is a recruitment agency specialized in the field of Life Sciences, Medical Devices, In Vitro Diagnostics and Biotechnologies. We recruit specific profiles from the development of a product or solution to the marketing phase including highly scientific and technical profiles. Research and development, quality, regulatory affairs, clinical, field specialist, business, marketing profiles to c-level positions in France and worldwide. We share our knowledge and force with startups, medium-sized and major companies in medical device to structure their organization. Christine Horvais, the founder, has set up a European network of consultants … Type: SMB Activities: biotech deeptech healthtech martech Technologies: Synthetic Biology | 12 | 1 | 6 | 11 | |
Apodis [Automatic translation follows] Connects the players in the medicine sector around the patient #GoodUse #PatientEmpowerment #DrugDisruption #eHealth #AI Apodis is the mobile and web application that connects the players in the medicine sector around the patient to support them in the proper use and compliance with their treatment. Our vision: transforming access to care by allowing patients to become actors in their daily health Apodis addresses two major issues for patients and our health system: - Drug shortages that have been increasing for 20 years - The misuse of drugs that results in more than 1 million days of hospitalization … Type: NGO, Think-tanks, Ed, & Culture SMB Activities: healthtech Technologies: Synthetic Biology | 34 | 7 | 35 | 15 | |
SynapCell We identify your most effective drug candidates in vivo with objective and translational measures within the brain. #EEG SynapCell is a Brain-focused biotechnology company that provides drug developers with robust and unbiased endpoints on drug efficacy in vivo, at the preclinical step. We use quantitative, EEG-based methods to longitudinally monitor a drug effect on translational models, following clinical-like protocols. Our capabilities include dose-response studies, pharmacodynamics, biomarker identification and modulation, disease-modifying assays, model phenotyping, as well as phenotypic screening for lead selection and validation. Our expertise in Neuroscience covers Epilepsy, Parkinson's disease, Essential Tremors as well as information processing defects such … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 5 | 7 | 41 | |
Fluofarma Scientist-to-Scientist Fluofarma, a Porsolt company, joins drug discovery projects to bring tailored solutions in cell biology and high-content analysis. Specialized in assay design, the French preclinical CRO develops and performs cell-based assays and quantifies biomarkers in blood and tissues using different high-content imaging and flow cytometry technologies. Fluofarma's contract research services are based on the following capacities: CUSTOM BIOLOGICAL MODELS > Generation of primary cell cultures, cell lines, 3D spheroids > Development of multi-cell type culture systems in 2D & 3D > Preclinical and clinical samples : whole blood, solid tissues and tissue microarrays (TMAs) ADAPTATION & DEVELOPMENT OF CELL-BASED … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
NORAKER [Automatic translation follows] Bioglass Solutions for Bone Regeneration NORAKER, a French player in regenerative medicine, is dedicated to promoting bone reconstruction for patients who have undergone orthopedic or dental surgery. Spin-off from INSA Lyon in 2005, NORAKER innovates with its mastery of a biomaterial with exceptional properties: bioactive glass. NORAKER has been distributing its implants since 2015, with an international presence in more than 40 countries. The company is committed to close and regular collaboration with surgeons and healthcare professionals to always better meet the requirements of the medical community. NORAKER products are used in orthopedic, spinal, CMF, ENT and … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 21 | 5 | 11 | 42 | |
GENFIT Dedicated to improving the lives of patients with liver diseases characterized by high unmet medical needs. GENFIT is a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. GENFIT is a pioneer in liver disease research and development with a rich history and strong scientific heritage spanning more than two decades. Its capacity to develop high potential assets, from early-stages to late development and pre-commercialization stages, is illustrated through the successful 52-week readout of its Phase 3 trial (ELATIVE®) evaluating elafibranor in Primary Biliary Cholangitis (PBC). Today, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 5 | 5 | 190 | |
Vect-Horus Enhancing the transport of therapeutic and imaging agents using versatile and flexible targeting technologies VECT-HORUS, Breaking barriers Vect-Horus designs and develops vectors that facilitate targeting and delivery of therapeutic or imaging agents to organs, including the brain and tumours. Vect-Horus combines these different agents to its vectors that specifically target various receptors, allowing these agents to cross natural barriers (first and foremost the blood-brain-barrier) which limit access of therapeutic or imaging agents to their targets. The proof of concept of the technology has already been established in animal models using different vectorized molecules. Vect-Horus endorces a mixed business model, based … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 24 | 6 | 10 | 46 | |
Capital Cell [Automatic translation follows] https://t.co/YVyBFPnY4V Type: SMB Activities: deeptech Technologies: Synthetic Biology | 19 | 2 | 11 | N/A | |
23andMe 23andMe, headquartered in Sunnyvale, CA, is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. The platform also powers … Type: Large company Activities: biotech deeptech Technologies: Synthetic Biology | 27 | 7 | 6 | 866 | |
DYSIS Medical DYSIS is computer-aided colposcopy with cervical mapping that helps healthcare professionals detect cervical lesions. DYSIS® is computer-aided colposcopy with innovative cervical mapping that quantifies acetowhitening and creates the color-coded DYSISmapTM to help healthcare professionals detect cervical lesions. The IMPROVE-COLPO study demonstrated an increased detection of patients with high-grade lesions by 44% when the DYSISmap was used for biopsy selection after a thorough visual colposcopic assessment. Additionally, high-resolution images, video (including exam playback) and a patient report improve documentation, patient communication and help healthcare professionals direct patients with greater assurance for screening, treatment or conservative management using SMARTtrackTM, a side-by-side comparison … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 21 | |
Palobiofarma S.L. Advancing healthcare through innovative adenosine receptor-based drugs Palobiofarma S.L. is a Spanish biopharmaceutical company dedicated to discovering and developing innovative drugs based on the modulation of adenosine receptors. Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 1 | 0 | 19 | |
Stragen Focusing on innovation for health solutions since 1990, Stragen is a global player in the development, registration and distribution of Generic drugs and Consumer Health products. Starting as a small API trading platform 30 years ago in Geneva, Switzerland, today Stragen operates in over 60 markets through a network of dynamic and collaborative partners, employing over 150 people and working with 10 dedicated affiliates worldwide. As a result of decades of experience and expertise in R&D, combined with our continuous commitment to advancing public health, we invest in the fundamental research through to the delivery of innovative and trusted health … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 113 | |
Noblegen Inc Champions of science, on a mission to rebalance the world from the microbial world up! Noblegen is an advanced digital biology company that employs microorganisms to reshape the world’s linear food systems with efficient and affordable circular solutions. We are champions of science on a mission to reinvent our future and disrupt conventional practices to rebalance planet and life, using microbes and fermentation technology. In our first phase of commercialization we have reinvented the world’s approach to food & agriculture. Our next phases of commercialization include biomaterials, health, energy, and space, among other industries. The company currently employs over 55 … Type: SMB Activities: it services Technologies: Synthetic Biology | 1 | 0 | 1 | 12 | |
Air-Tite Products Co., Inc. Air-Tite Products is a company of syringe and needle experts, specializing in hypodermics since 1926. We focus on providing personalized service to our customers and distinguish ourselves with hard-to-find niche products. Air-Tite Products is a direct importer of high-quality products from global leaders in more than 10 different countries. Whether you need an off-the-shelf solution from our hundreds of stocked products, or to leverage the capabilities of our manufacturing partners for a custom solution, Air-Tite can identify options that best meet your individual application’s requirements. We supply hypodermics to diverse industries from human healthcare to pharmaceuticals, animal health, laboratory, industrial, … Type: SMB Activities: spacetech Technologies: Synthetic Biology | 3 | 0 | 3 | 18 | |
AVNA Innovation Partners for Life. AVNA (formerly OKAY Industries) is a contract manufacturing partner for leading medical device OEMs. We produce high-quality, complex components and sub-assemblies for precision powered, robotic, and mechanical medical and surgical devices. Our fully-integrated services and continual investment in advanced technology have positioned us as a market leader in metal forming, Multi-Axis CNC and Laser-Swiss machining, laser processing, plastic injection and over-molding, micro-machining, metal stamping, and automated assemblies. A wide variety of in-house manual, semi, and fully automated parts cleaning and finishing services combined with machine design, build, and automation technologies allow us to customize solutions that … Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 296 | |
Metaphase - part of Aptar Pharma User Centered Solutions in UX, HFE & ID Metaphase in now a part of Aptar Pharma. Our user centered consulting services bring together expertise in industrial design & research, user-experience & human factors, market insights & program development, product development & commercial scale-up and launch & post market optimization. * Specialist in high-touch products * Experts in HF & Research * Global network of usability labs * World class medical device solutions * Brand success and launch readiness * End to end enterprise-wide solutions provider ergonomics, strategy, research, product development, design, ergonomic design, product design, packaging design, ergonomic design audits, … Type: SMB Activities: deeptech Technologies: Synthetic Biology | 2 | 0 | 2 | 13 | |
DCAT (Drug, Chemical & Associated Technologies Association) The Premier Business Development Association for the Global Bio/Pharmaceutical Manufacturing Value Chain Founded in 1890, the Drug, Chemical & Associated Technologies Association, Inc. (DCAT) is a not-for-profit, corporate member-supported, and volunteer-led global business development association for companies engaged in the Bio/Pharmaceutical manufacturing value chain. DCAT has been providing a life-long collegial community for its Member Companies, and their representatives, for over 130 years. DCAT helps build relationships within its unique member company profile that includes the Bio/Pharmaceutical industry’s entire manufacturing value chain. DCAT creates objective, expert-driven education programs and informational services so its Member Companies can easily gain insight into … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech edtech Technologies: Synthetic Biology | 11 | 1 | 11 | 36 | |
LAUS Group Small enough to care and big enough to deliver LAUS is today an internationally recognized GLP certified testing facility (CRO) working in five areas of expertise: Analytical Chemistry, Physico-Chemistry, in vitro–Toxicology, Ecotoxicology, and Environmental Fate. LAUS provides a strong portfolio of studies in all five areas for a great variety of products like chemicals, pesticides, biocides, medical devices, medicinal products for veterinary and human use, cosmetics, food additives, and novel food. These tests are crucial for 1. registration purposes (e.g. REACH, BPR), 2. classification (e.g. GHS, CLP, Water Hazard Classes), 3. application for labeling (e.g. Ecolabel), 4. assessment of potential … Type: SMB Activities: biotech deeptech foodtech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 75 | |
Delmont Imaging Imaging all the women Delmont imaging is a company located in La Ciotat, France. Specialized in the design of medical devices for gynecology, our mission is to improve the care and management of all patients, regardless of age and future, by providing innovative, effective and less traumatic solutions. Our products are in line with the general trend of the outpatient surgery and more particularly with the «See & Treat» concepts. Gynecology, Hysteroscopy, and Medical imaging Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology | 1 | 0 | 1 | 23 | |
Verve Therapeutics We are on a mission to protect the world from cardiovascular disease. Verve Therapeutics is a clinical-stage biotechnology company created with a singular focus: to protect the world from heart disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene editing, the company aims to develop transformative, once-and-done therapies for coronary heart disease. Verve’s gene editing medicines are designed to safely edit the genome of adults and mimic naturally occurring gene variants to permanently lower LDL cholesterol and triglyceride levels. The company is advancing a pipeline of precision genetic medicines, led by VERVE-101, which is being developed initially … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 13 | 0 | 9 | 295 | |
Pathwaves - Supermind Your Path to Better Brainwaves Pathwaves has become Supermind. Creator of Neural EmpowermentTM a proprietary, multi-dimensional and innovative methodology that uses the powerful principles of neuroplasticity along with integrative biofeedback and timeless healing modalities to help people attain an optimal state of mental, emotional, spiritual, and physical harmony. As a for-profit, social impact company, Pathwaves was established in 2016 with eight years of research and development preceding its launch. The Pathwaves team uses advanced technology to provide clients the tools to re-parent their cells utilizing their Brainwave Positioning SystemTM(BPS) – customized for each individual’s genetics, current biology, beliefs, life experiences, … Type: Startup Activities: biotech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
Illumiheal Creating healing technologies to help pets live longer, happier and healthier lives. Illumiheal creates healing technologies to help pets live longer, happier and healthier lives. Illumiheal, makers of PetThera. PetThera is a therapeutic device for pets to treat chronic skin conditions, decrease inflammation, reduce pain, speed wound healing, accelerate post surgical rehabilitation time, and more. PetThera is designed with pet parents in mind to use on their pets in the comfort of their own home. PetThera boosts your pet’s quality of life and revitalizes their natural well being. Type: Startup Activities: pettech healthtech Technologies: Synthetic Biology | 4 | 0 | 4 | 1 | |
MycoTechnology, Inc. Fusing nature, science and culinary innovation to transform the food industry for the better. MycoTechnology is a food ingredient company that fuses nature, science, and culinary innovation to transform the future of food. Harnessing the power of fungi, MycoTechnology solves some of the most pervasive challenges in the industry to improve our food system– for people and the planet. Taste Defects, Taste Modulation, Flavor Modulation, Fungi Fermentation, Bitterness, Astringency, Sourness Modulation, Sugar Reduction, Plant Based Protein, Mushrooms, and Plant Based Type: Startup Activities: foodtech Technologies: Synthetic Biology | 5 | 1 | 3 | 85 | |
AUM Biosciences Advancing precision oncology therapeutics designed to deploy multi-faceted inhibition to reverse cancer resistance AUM Biosciences is focused on advancing a clinical pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance biotech, oncology, drug development, Asian-biotech, Precision medicine, Digitalhealth, cancer, and small molecules Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 1 | 1 | 18 | |
Unicorn Biotechnologies Automated, modular, scalable biomanufacturing We industrialize cell culture. Unicorn is building machines to standardize, automate, and scale cell culture processes and manufacturing workflows, starting with iPSCs. Our goal is to enable better research, faster translation to products and therapeutic candidates, and to remove the barriers to scaled manufacture. So that we can help create a more sustainable future on planet Earth, where all people live healthier, longer lives. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 3 | 14 | |
Arctoris Arctoris is a tech-enabled Contract Research Organization (CRO) headquartered in Oxford, UK. Arctoris is a tech-enabled Partnership Research Organization (PRO) headquartered in Oxford. We combine our unique automation platform, Ulysses, with a world-class team of excellent laboratory scientists to guide and rapidly progress our partners’ drug discovery programs from target to candidate. Data is the lifeblood of research, and “Better Data leads to Better Decisions”. Our excellent service is built on: 1) Data quality: generating large reproducible datasets by leveraging robotics and wet lab automation, in turn empowering improved decision-making. 2) Our world-class team of experienced scientists: a true partner … Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology A.I. - Machine Learning | 9 | 1 | 8 | 38 | |
Biotalys Transforming crop protection We are an agricultural technology (agtech) company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on our ground-breaking technology platform, Biotalys is developing a broad pipeline of crop protection products with novel modes of action, addressing key crop pests and diseases across the whole value chain, from soil to plate. Biotalys’ unique protein-based biocontrols aim to combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. We are on track to have … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 4 | 8 | 68 | |
RefleXion Medical SCINTIX biology-guided radiotherapy is now FDA cleared. SCINTIX biology-guided radiotherapy now FDA cleared. SCINTIX® therapy detects and responds to signals emitted from the cancer itself and, for the first time, uses them to deliver immediate treatment for tumors in the lung or bone that may arise from primary or metastatic disease. cancer care, radiation therapy, life sciences, medical devices, biotechnology, oncology, manufacturing, PET scanner, electrical engineering, product engineering, algorithms engineer, new product development, and software engineering Type: Startup Activities: biotech deeptech healthtech manufacturing Technologies: Synthetic Biology | 3 | 3 | 1 | 258 | |
Inspirna, Inc. Converting cancer to a manageable, chronic condition Inspirna, Inc., is a privately-held clinical-stage biopharmaceutical company focused on the discovery and development of novel cancer drugs that target key pathways in cancers of high unmet need. Inspirna’s lead drug candidate, ompenaclid (RGX-202), is an orally-administered small molecule that targets the CKB/SLC6A8 pathway, which when activated enables the generation of ATP in response to tumor hypoxia. Ompenaclid is currently being tested in multiple mid-stage clinical trials in patients with advanced or metastatic RAS mutant colorectal cancer. Inspirna’s second clinical stage drug candidate, abequolixron (RGX-104), is an oral small molecule activator of LXR/APOE … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 2 | 1 | 34 | |
Artios Taking control of the DNA Damage Response (DDR) Artios is on a mission to kill cancer by exploiting DNA damage response (DDR) and repair pathways that are leveraged by cancer cells to promote their survival. Our specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR. We have built an extensive DDR focused pipeline designed to address areas of high unmet needs across solid tumour indications including our ATR inhibitor, ART0380, and our Polθ inhibitor ART6043, as monotherapy and combination treatments. … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 8 | 3 | 1 | 127 | |
MOBILion Systems, Inc. The MOBILion team is focused on developing instruments that improve how we predict, diagnose and treat disease. MOBILion’s technology makes it easy to separate, identify and analyze the most challenging molecules that other instruments fail to detect. Our higher resolution, faster analysis and simpler workflows reveal molecules that are most important in characterizing biologic therapeutics, discovering biomarkers, and improving the accuracy of diagnostic tests. We make today’s treatment’s safer and more effective, empower tomorrow’s disease prediction and diagnosis, and accelerate the development of new therapies. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 1 | 2 | 58 | |
ProQR Therapeutics Advancing our proprietary AxiomerTM RNA-editing platform technology Changing lives is what drives us at ProQR Therapeutics. We are advancing our proprietary AxiomerTM RNA-editing platform technology. Our highly energetic team strives to combine innovative technologies and entrepreneurism to make a meaningful impact on the lives of individuals and the people around them. If you are up to this challenge and like to be part of our team, check out our website for vacancies: http://www.proqr.com/careers/ RNA therapeutics, Drug development, Rare Diseases, Genetic Diseases, Orphan drugs, Pharmaceuticals, and RNA editing Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 3 | 1 | 179 | |
Regenosine Harnessing the healing potential of adenosine for tissue regeneration Privately held company focused on developing and marketing first-in-class regenerative therapies for osteoarthritis. Our proprietary platform technology harnesses the healing potential of the purinergic system which plays a critical role in maintaining cartilage homeostasis. Our lead product is a proprietary formulation for regenerating cartilage in joints with established osteoarthritis, targeting a rapidly growing joint preservation market. Our goal is to offer patients a disease modifying therapy with uncompromising efficacy relative to existing technologies. By developing this disease modifying therapy, we will significantly improve clinical outcomes and patient quality of life, and … Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 | |
MedtecLIVE Connecting the medical technology supply chain 05.-07.05.2026 Stuttgart, Germany MedtecLIVE with T4M: leading springtime event for medical technology sector to alternate between Stuttgart and Nuremberg! MedtecLIVE is where product developers and purchasing managers from distributors and OEMs come together with the leading suppliers of medical technology in Europe. The event alternates between the two most important medical technology regions in Germany and covers the entire supply chain. The trade fair is accompanied by a comprehensive supporting programme such as the MedtecSUMMIT organised in partnership with national and international associations and clusters that reflects the most important issues and trends in … Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology 3D Printing | 6 | 2 | 4 | 3 | |
MedNest MedNest sources and develops the business of innovative Medical Technology companies for the US markets, with an exclusive focus in the Drug - Device & Diagnostic - Healthcare IT convergence space. MedNest offers Business and Clinical Operations services to companies looking for an experienced partner to operate their organic or inorganic growth projects, in particular during transition times (i.e. US Market Access preparation, deal search or post-acquisition integration), when execution risks and time to market must be minimal. Medical Devices, Convergent Medical Technologies, Medical Imaging, and Drug Delivery Systems Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology | 2 | 2 | 0 | 1 | |
Scemed by Winncare [Automatic translation follows] Improving the lives of people who are losing their autonomy and those who care for them. A major player in the medical equipment market in France, Scemed by Winncare is a specialist in hygiene, transfer and disinfection equipment in healthcare facilities. SCEMED develops innovative concepts that provide real solutions for improving patient care and improving the working conditions of healthcare staff. Our worlds: - HYGIENE: medicalized bathtubs, well-being, therapeutic - SHOWER EQUIPMENT: shower trolleys and chairs, bariatric range - TRANSFER: ceiling rail system, verticalizers, mobile patient lifts, harnesses - DISINFECTION: washer-disinfector, layout and storage solutions Our product … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 6 | 3 | 5 | 40 | |
Laboratoires BIOTIC Phocea [Automatic translation follows] Innovative solutions in dermo-pigmentation and cosmetics Founded in 1999 by Doctor Tiziano, BIOTIC Phocea Laboratories have recognized expertise in restorative and corrective dermopigmentation. Based in Marseille, we specialize in the design and manufacture of high-quality sterile pigments, meeting the strict standards of CEIIb medical devices (BIOCHROMADERM®, BIOCHROMAEYES®, RADSAFE®) as well as the latest European recommendations (REACH) in permanent makeup. Our expertise extends from medical dermopigmentation, used for corrective or restorative procedures (scars, post-surgical reconstruction, etc.), to aesthetic pigmentation (eyebrows, lips, eyes, scalp, etc.). Our dermopigmentation training center welcomes novice and expert dermopigmentation trainees. This center offers an … Type: SMB Activities: cosmetics healthtech manufacturing Technologies: Synthetic Biology | 1 | 0 | 1 | 28 | |
ACM Pharma [Automatic translation follows] Your specialized partner in contamination control Laboratory for microbiological analysis of health products. Located in the heart of the Centre Val de Loire region near the major pharmaceutical and cosmetic centers, the microbiology laboratory, run by specialized pharmacists and scientists, brings its know-how and more than 10 years of experience to the service of the pharmaceutical industries, manufacturers of medical and cosmetic devices. Analyses carried out within the laboratory: Microbial contamination, endotoxins, sterility testing, bacterial identification, antibiotics, water analysis, challenge tests, testing of antiseptics and disinfectants. Microbiology laboratory, Monitoring of clean rooms, Challenge test, Bacterial identification, Endotoxin, … Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 64 | |
GTP Bioways Customer-centric and science-driven CDMO supporting biopharma companies from R&D to market GTP Bioways is an expert and fast-growing contract development and manufacturing organisation (CDMO) offering uniquely customised process development and manufacturing services for biologics, antibody-drug conjugates and nanodrugs. With cutting-edge facilities located in France, GTP Bioways supports biopharma companies in bringing their innovative molecules from research to clinic and market. Biologics, Nanodrugs, Process Development, Analytics, Biopharmaceuticals, and GMP Manufacturing Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 21 | 5 | 20 | 149 | |
APC Europe Global Leader in Functional Proteins - Helping Animals Thrive 📣 Who is APC Europe? We are the world’s largest manufacturer of Spray-Dried Plasma, Hydrolyzed Proteins and other High-Quality Proteins. Our main goal is researching and producing feed ingredients with the best quality to enhance health and animal nutrition. APC Europe is part of the LGI Group and subsidiary of APC Inc. -Ankeny (Iowa). 🔧 What APC Europe does? At APC, we market, research and develop products principally derived from blood proteins based on customer need. We efficiently procure and manufacture safe and effective products for use in animal, with a … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 1 | 1 | 67 | |
Kinoxis Therapeutics Pty Ltd Kinoxis Therapeutics is a private, Australian-based, clinical stage biotechnology company developing first-in-class therapeutics to address the escalating demand for effective treatments for substance use disorders and social dysfunction in neurological and psychiatric disorders. Kinoxis’ development candidates are novel, small molecules that were discovered through a comprehensive medicinal chemistry and screening program at the University of Sydney. Kinoxis is backed by Uniseed, Australia’s longest running venture fund, and a consortium of sophisticated investors, and secured funding from the US National Institutes of Health National Institute on Drug Abuse for the development of its lead compound to mitigate opioid withdrawal symptoms. Kinoxis’ … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 | 1 | 16 | |
LABORATOIRE POLIDIS [Automatic translation follows] Founded in 1986, Laboratoire POLIDIS is a human-sized company that has built its reputation in the field of medical devices. Its recognized expertise in the world of condoms also extends to pregnancy tests, ovulation tests, pain relief gels, food supplements as well as a wide range of anti-lice and nit products (shampoo, care cream, two-phase lotion and nit remover). Its status as a French manufacturer and the excellent reputation of its products make Laboratoire POLIDIS a privileged partner of the French Pharmacy. Innovation is the key to success. This is why we ask our teams for the … Type: SMB Activities: manufacturing deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 17 | |
Hôpital Privé La Casamance [Automatic translation follows] 160 liberal practitioners with many specialties practice there thanks to a high-level technical infrastructure. In addition, multidisciplinary medical teams provide safe care for hospitalized or emergency patients 24 hours a day. 500 health professionals are present daily with patients. The establishment, organized into different activity centers, offers a complete care pathway that is broken down into diagnostic, therapeutic and rehabilitation care. Medical and interventional cardiology, Specialty medicine, Specialty surgery, Emergency medicine, Diagnostics, Perinatality, and Follow-up and rehabilitation care Type: SMB Activities: healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 233 | |
Theralase Technologies (TSXV: TLT) Destroying cancer at the speed of light Theralase® Technologies is a Canadian clinical stage pharmaceutical company dedicated to the research and development of light activated Photo Dynamic Compounds and their associated drug formulations intended to safely and effectively destroy various cancers. We strive to continuously improve the quality of life for those afflicted with cancer by focusing our research and development on preventing, alleviating and treating diseases. Serving our higher purpose to bring hope for cancer treatments to light. Founded in 1994, Theralase’s operations are divided into two divisions: the production of therapeutic laser technology for commercial applications, and the … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 1 | 1 | 0 | 34 | |
Rhythmlink International, LLC Improving Patient Care with Innovative Products Rhythmlink International, LLC designs, manufactures and distributes medical devices and provides custom packaging, private labeling, custom products and contract manufacturing solutions to its customers. Rhythmlink is recognized as a leader within its field at providing the important physical connection between patients and the diagnostic equipment to record or elicit neurophysiologic biopotentials. Based in Columbia, SC, Rhythmlink was established in 2002 and is owned and operated by CEO Shawn Regan and COO Michael O’Leary. Rhythmlink’s advancements and improvements in the areas of technology, business development and corporate branding have been recognized both on a national … Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology | 0 | 0 | 0 | 80 | |
Quinton Biotech Labs [Automatic translation follows] We are the first biotechnology company to offer the possibility of taking care of your health with seawater specialties. Quinton Laboratories are pharmaceutical laboratories dedicated exclusively to the preparation of cold microfiltered seawater. Direct heirs of the French biologist and physiologist René Quinton, this laboratory is distinguished by scrupulously following the original method of its founder, which we have been able to update according to the European pharmacopoeia. We are at the complete disposal of health professionals or the general public to satisfy their desires for knowledge about Marine Therapeutics and the use of Quinton specialties. Quinton … Type: SMB Activities: healthtech Technologies: Synthetic Biology | 1 | 0 | 0 | 65 | |
UroMems UroMems is a biotechnology company based out of 5, rue Raymond Chanas, 38320, Eybens, FRANCE Urologie and Dispositifs médicaux Type: SMB Activities: deeptech healthtech biotech Technologies: Synthetic Biology | 13 | 2 | 0 | 63 | |
Fitabeo Therapeutics Innovating to Enhance Quality of Life Fitabeo Therapeutics is a clinical-stage specialty pharmaceutical company that develops and commercialises a differentiated portfolio of innovative medicines focusing on indications where existing treatments are inadequate for the target population. It deploys breakthrough technologies to develop medicines that enable patient autonomy, decentralise patient care and provide superior health outcomes. Oral Thin Films, Geriatrics, Paediatrics, Patient autonomy, Equitable Access, Innovative medicines, Medication adherence, Central Nervous System, Women's Health, and Neurology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 5 | |
Genewity B.V. Genewity is a pioneering biotech start-up focused on advanced thymus-driven therapies for immune reconstitution. Supported by the extensive business expertise of our management and advisors, we are at the forefront of developing and commercialising breakthrough therapies. With over 150 years of combined experience in immunology and gene therapy, our team is uniquely positioned to drive advancements in the field. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 15 | |
MiMARK Discovering new biomarkers for Women’s Health In MiMARK, we care for women's health. We are specialized in the discovery, verification and validation of biomarkers to develop new solutions for gynecological patients. Abnormal uterine bleeding affects 14M between women in EU and US yearly (in women between 50 and 75 years old). Diagnosis of endometrial cancer is mandatory for all those women as 10% of those will be diagnosed with the disease. Current diagnosis is based on the pathological examination of an endometrial biopsy (pipelle biopsy), but this fails to diagnose in up to 30% of patients, and provides an inaccurate … Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 5 | 1 | 4 | 24 | |
EBAMed Ultrasound Guidance during Radio Ablation Treatment of Cardiac Arrhythmias EBAMed (External Beam Ablation Medical Devices) is developing an Ultrasound Imaging Solution to enable non-invasive treatment of Cardiac Arrhythmias. The device (CardioKit) offers the following functionalities: target position verification before treatment (to aid in patient setup), Cardiac Motion Monitoring during treatment, Respiratory Gating and Cardiac Gating. Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology | 0 | 0 | 0 | 11 | |
Hooke Bio Ltd. Biotech Startup who have developed a fully integrated high throughput screening system for 3D microtissues Hooke Bio Ltd. was founded in 2014 by Professor Mark Davies at Stokes Laboratories, University of Limerick (UL), a research center which has a rich history of microfluidic entrepreneurship. Hooke Bio spun out from the UL in 2017 and is currently based in Shannon, Co. Clare, Ireland. The company is named after Robert Hooke (scientist, astronomer, engineer and architect). He was the first person to image a microorganism using a microscope and coined the term "cell". Prior to 2017, Hooke Bio was funded by two … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 14 | |
Hooked Foods Leading the protein transformation for healthier people & planet Leading the transition to a healthier marine ecosystem by serving delicious plant-based seafood for everyone to enjoy. Type: Startup Activities: foodtech Technologies: Synthetic Biology | 2 | 2 | 0 | 18 | |
Hamlet BioPharma An innovative pharmaceutical company with a broad portfolio of projects for the treatment of cancer and infections Hamlet BioPharma AB is a pharmaceutical company with strong links to research, working with natural and biological substances. The company was formed through the merger of two pharmaceutical companies, Hamlet Pharma AB and SelectImmune Pharma AB, and is listed on the Spotlight Stock Market. Hamlet BioPharma is a formidable pharmaceutical company specializing in the development of drugs for the treatment of cancer and infectious diseases. The company has a portfolio of a total of ten drug projects, three of which are in Phase … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 0 | 0 | 8 | |
Cytovation Creating transformative medicines for patients with cancer Cytovation is a clinical stage immuno-oncology biotech developing first-in-class immunotherapies. CyPep-1, its lead asset, is a synthetic peptide engineered to selectively target tumor cells. CyPep-1 has a unique dual MoA applicable across solid tumors: (1) direct tumor-specific membrane lysis and in-situ vaccination, combined with (2) immune activation through inhibition of the β-catenin pathway. Building on strong FIH clinical data, Cytovation is advancing CyPep-1 to POC/pivotal clinical development with a focus on b-catenin-driven cancers. Biotech, Oncology, and Immuno-oncology Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 0 | 0 | 12 | |
Mighty Well Mighty Well creates innovative products in the Adaptive Wear market, which is expected to reach $393B by 2026 (CBS News), for the 133 million Americans who live with a chronic condition. Mighty Well applies sportswear fabric technology to the medical industry and is building a digital supportive community of Friends in the Fight for our consumers. We are leading the global charge of helping patients and caregivers turn sickness into strength. Mighty Well was Co-Founded out of CEO, Emily Levy's, experience as a patient battling Lyme disease and living with long term medical devices. Type: Startup Activities: healthtech fashtech Technologies: Synthetic Biology | 5 | 2 | 5 | 1 | |
Nano3D Biosciences Nano3D Biosciences (n3D) is a biotechnology startup located in Houston, TX focused on 3D cell culture solutions for biomedical research, drug discovery, toxicology, precision medicine, and regenerative medicine. Our core technology, magnetic 3D bioprinting, works by magnetizing cells and aggregating them with magnetic forces into models that represent native tissue environments. The advantages of this platform over other 3D cell culture and bioprinting platforms are speed, ease, and handling. n3D offers products and services around this technology, with a worldwide distribution network, including an OEM partnership with Greiner Bio-One Cell culture, Assay development, 3D cell culture, Precision medicine, Toxicology, and … Type: Startup Activities: biotech healthtech deeptech Technologies: 3D Printing Synthetic Biology | 1 | 0 | 0 | 1 | |
StemTek Therapeutics StemTek Therapeutics is a start-up biotechnolgy company dedicated to accelerating drug discovery in cancer using cutting edge technology, world-class science and a stem cell centric point of view for cancer therapy. Our mission is to help design novel treatments for cancer targeting cancer stem cells. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 0 | 1 | 1 | |
WHEYD Stomach-friendly Protein Powders Designed for Elite Level Athletes To Improve Performance and Recovery. Simply put, our whey is different to the rest, as is the way we do business and work with suppliers & amazing customers. We provide the highest quality, stomach-friendly, Irish whey protein in delicious flavours, both in single-serve sachets and larger bags. We help those looking to increase their protein intake (20g per portion), while keeping their fat and sugar intake low. By providing the lowest calorie whey protein (86 calories a portion), sustainably sourced from Irish dairy cows, we aim to revolutionise the world of whey … Type: Startup Activities: healthtech sporttech Technologies: Synthetic Biology | 0 | 0 | 0 | 2 |